Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies

Cancer Treatment Reviews

Volumn 49, Issue , 2016, Pages 65-76

  Lambertini, Matteo ^a,b   Santoro, Luigi ^c   Del Mastro, Lucia ^b   Nguyen, Bastien ^d   Livraghi, Luca ^e   Ugolini, Donatella ^f   Peccatori, Fedro A ^c   Azim, Hatem A ^a,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF GENOA   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d JULES BORDET INSTITUTE   (Belgium)

^e Department of Obstetrics and Gynecology   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Age at first birth; Breast cancer risk; Breast cancer subtypes; Breastfeeding; Parity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BEHAVIOR ASSESSMENT; BREAST CANCER; BREAST FEEDING; CANCER CLASSIFICATION; CANCER RISK; DATA ANALYSIS; DISEASE ASSOCIATION; HEALTH BEHAVIOR; HUMAN; MATERNAL AGE; META ANALYSIS; PARITY; PRACTICE GUIDELINE; REPRODUCTIVE BEHAVIOR; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; BREAST NEOPLASMS; FEMALE; METABOLISM; REPRODUCTIVE HISTORY; STATISTICS AND NUMERICAL DATA; TRIPLE NEGATIVE BREAST NEOPLASMS;

BREAST FEEDING; BREAST NEOPLASMS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MATERNAL AGE; PARITY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCTIVE BEHAVIOR; REPRODUCTIVE HISTORY; RISK FACTORS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84982187262     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2016.07.006     Document Type: Review

References (48)

1. [1] The Globocan Project. Available at: http://www.globocan.iarc.fr. [accessed July 19, 2016].
2. [2] Coates, A.S., Winer, E.P., Goldhirsch, A., Gelber, R.D., Gnant, M., Piccart-Gebhart, M., et al. Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 26 (2015), 1533–1546.
3. [3] Bernstein, L., Ross, R.K., Endogenous hormones and breast cancer risk. Epidemiol Rev 15 (1993), 48–65.
4. [4] Azim, H.A. Jr, Partridge, A.H., Biology of breast cancer in young women. Breast Cancer Res, 16, 2014, 427.
5. [5] Key, T.J., Pike, M.C., The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24 (1988), 29–43.
6. [6] Ma, H., Bernstein, L., Pike, M.C., Ursin, G., Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res, 8, 2006, R43.
7. [7] Anderson, K.N., Schwab, R.B., Martinez, M.E., Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144 (2014), 1–10.
8. [8] Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
9. [9] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
10. [10] Higgins, J.P.T., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002), 1539–1558.
11. [11] Macaskill, P., Walter, S.D., Irwig, L., A comparison of methods to detect publication bias in meta-analysis. Stat Med 20 (2001), 641–654.
12. [12] Phipps, A.I., Buist, D.S.M., Malone, K.E., Barlow, W.E., Porter, P.L., Kerlikowske, K., et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 22 (2011), 399–405.
13. [13] Phipps, A.I., Chlebowski, R.T., Prentice, R., McTiernan, A., Wactawski-Wende, J., Kuller, L.H., et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103 (2011), 470–477.
14. [14] Yang, X.R., Sherman, M.E., Rimm, D.L., Lissowska, J., Brinton, L.A., Peplonska, B., et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomark Prev 16 (2007), 439–443.
15. [15] Phipps, A.I., Malone, K.E., Porter, P.L., Daling, J.R., Li, C.I., Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113 (2008), 1521–1526.
16. [16] Millikan, R.C., Newman, B., Tse, C.-K., Moorman, P.G., Conway, K., Dressler, L.G., et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109 (2008), 123–139.
17. [17] Trivers, K.F., Lund, M.J., Porter, P.L., Liff, J.M., Flagg, E.W., Coates, R.J., et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20 (2009), 1071–1082.
18. [18] Dolle, J.M., Daling, J.R., White, E., Brinton, L.A., Doody, D.R., Porter, P.L., et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomark Prev 18 (2009), 1157–1166.
19. [19] Ma, H., Wang, Y., Sullivan-Halley, J., Weiss, L., Marchbanks, P.A., Spirtas, R., et al. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 70 (2010), 575–587.
20. [20] Xing, P., Li, J., Jin, F., A case–control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol 27 (2010), 926–931.
21. [21] Gaudet, M.M., Press, M.F., Haile, R.W., Lynch, C.F., Glaser, S.L., Schildkraut, J., et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130 (2011), 587–597.
22. [22] Islam, T., Matsuo, K., Ito, H., Hosono, S., Watanabe, M., Iwata, H., et al. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women. Ann Oncol 23 (2012), 2435–2441.
23. [23] Li, C.I., Beaber, E.F., Tang, M.-T.C., Porter, P.L., Daling, J.R., Malone, K.E., Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age. Breast Cancer Res Treat 137 (2013), 579–587.
24. [24] Ambrosone, C.B., Zirpoli, G., Ruszczyk, M., Shankar, J., Hong, C.-C., McIlwain, D., et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Cancer Causes Control 25 (2014), 259–265.
25. [25] Palmer, J.R., Viscidi, E., Troester, M.A., Hong, C.-C., Schedin, P., Bethea, T.N., et al. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J Natl Cancer Inst, 106, 2014.
26. [26] Horn, J., Opdahl, S., Engstrøm, M.J., Romundstad, P.R., Tretli, S., Haugen, O.A., et al. Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women. Cancer Causes Control 25 (2014), 881–889.
27. [27] Yang, X.R., Chang-Claude, J., Goode, E.L., Couch, F.J., Nevanlinna, H., Milne, R.L., et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103 (2011), 250–263.
28. [28] Islami, F., Liu, Y., Jemal, A., Zhou, J., Weiderpass, E., Colditz, G., et al. Breastfeeding and breast cancer risk by receptor status-a systematic review and meta-analysis. Ann Oncol 26 (2015), 2398–2407.
29. [29] DeSantis, C.E., Fedewa, S.A., Goding Sauer, A., Kramer, J.L., Smith, R.A., Jemal, A., Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66 (2016), 31–42.
30. [30] Hamilton, B.E., Martin, J.A., Ventura, S.J., Births: preliminary data for 2012. Natl Vital Stat Rep 62 (2013), 1–20.
31. [31] Centers for Disease Control and Prevention (CDC), Racial and ethnic differences in breastfeeding initiation and duration, by state - National Immunization Survey, United States, 2004–2008. MMWR Morb Mortal Wkly Rep 59 (2010), 327–334.
32. [32] Victora, C.G., Bahl, R., Barros, A.J.D., França, G.V.A., Horton, S., Krasevec, J., et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387 (2016), 475–490.
33. [33] Rollins, N.C., Bhandari, N., Hajeebhoy, N., Horton, S., Lutter, C.K., Martines, J.C., et al. Why invest, and what it will take to improve breastfeeding practices?. Lancet 387 (2016), 491–504.
34. [34] Koh, H.K., Piotrowski, J.J., Kumanyika, S., Fielding, J.E., Healthy people: a 2020 vision for the social determinants approach. Health Educ Behav 38 (2011), 551–557.
35. [35] Lambe, M., Hsieh, C., Trichopoulos, D., Ekbom, A., Pavia, M., Adami, H.O., Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331 (1994), 5–9.
36. [36] Meier-Abt, F., Bentires-Alj, M., How pregnancy at early age protects against breast cancer. Trends Mol Med 20 (2014), 143–153.
37. [37] Rajkumar, L., Guzman, R.C., Yang, J., Thordarson, G., Talamantes, F., Nandi, S., Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 6 (2004), R31–R37.
38. [38] Meier-Abt, F., Bentires-Alj, M., Rochlitz, C., Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection. Cancer Res 75 (2015), 803–807.
39. [39] Russo, I.H., Russo, J., Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 16 (2011), 221–233.
40. [40] Russo, J., Balogh, G.A., Russo, I.H., Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomark Prev 17 (2008), 51–66.
41. [41] Asztalos, S., Gann, P.H., Hayes, M.K., Nonn, L., Beam, C.A., Dai, Y., et al. Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila) 3 (2010), 301–311.
42. [42] Meier-Abt, F., Milani, E., Roloff, T., Brinkhaus, H., Duss, S., Meyer, D.S., et al. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res, 15, 2013, R36.
43. [43] Choudhury, S., Almendro, V., Merino, V.F., Wu, Z., Maruyama, R., Su, Y., et al. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell 13 (2013), 117–130.
44. [44] Turkoz, F.P., Solak, M., Petekkaya, I., Keskin, O., Kertmen, N., Sarici, F., et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22 (2013), 344–350.
45. [45] Dontu, G., El-Ashry, D., Wicha, M.S., Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 15 (2004), 193–197.
46. [46] Milanese, T.R., Hartmann, L.C., Sellers, T.A., Frost, M.H., Vierkant, R.A., Maloney, S.D., et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98 (2006), 1600–1607.
47. [47] Yang, X.R., Figueroa, J.D., Falk, R.T., Zhang, H., Pfeiffer, R.M., Hewitt, S.M., et al. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res, 14, 2012, R64.
48. [48] Faupel-Badger, J.M., Arcaro, K.F., Balkam, J.J., Eliassen, A.H., Hassiotou, F., Lebrilla, C.B., et al. Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst 105 (2013), 166–174.